Semaglutide & Alzheimer’s: EVOKE(+) Trial Results & Insights (2026)
The search for effective treatments for Alzheimer’s disease continues to face setbacks. Recent results from the large-scale, phase 3 EVOKE(+) trials indicate that semaglutide, a medication … Read more